• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状携带者中乙肝病毒DNA的两种不同状态:HBe抗原阳性与抗-HBe阳性无症状携带者。

The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.

作者信息

Fujiwara K, Yokosuka O, Ehata T, Chuang W L, Imazeki F, Saisho H, Omata M

机构信息

First Department of Medicine, Chiba University School of Medicine, Chiba City, Japan.

出版信息

Dig Dis Sci. 1998 Feb;43(2):368-76. doi: 10.1023/a:1018870709286.

DOI:10.1023/a:1018870709286
PMID:9512133
Abstract

During the course of hepatitis B virus (HBV) infection, there exists a long period of normal liver function tests with different states of HBeAg/Ab. As the state of HBV in asymptomatic carriers was not well characterized, we quantitatively and qualitatively examined HBV in both HBeAg-positive and anti-HBe-positive asymptomatic carriers. Sera from 10 HBeAg-positive and 27 anti-HBe-positive asymptomatic carriers were analyzed. The amount of HBV DNA was determined by dot-blot hybridization and polymerase chain reaction. The mutations in precore and core regions, spanning 636 nucleotides, of hepatitis B virus were examined by directly sequencing the amplified HBV DNA. HBV DNA was detected in all 10 HBeAg-positive cases, whereas it was found in only 7 of 27 (26%) anti-HBe-positive cases by the nested PCR method. The mean amount of HBV DNA in HBeAg-positive cases was 10(9.1 +/- 0.7) copies/ml, while that in anti-HBe-positive cases was 10(1.0 +/- 1.5) copies/ml. There were no missense mutations in the entire precore and core genes of HBV DNA taken from HBeAg-positive asymptomatic carriers. In contrast, many mutations (mean 9.0 +/- 3.3, range 6-14) were detected in the core gene of seven anti-HBe-positive asymptomatic carriers including two cases with increments of the mutations. Analysis of the precore region revealed three wild-type and four mutant-type (including one coexisting with wild-type) cases. These data suggest that HBV exists in quite different ways in "asymptomatic" carriers; in the HBeAg-positive phase HBV probably coexists with the host and remains as the wild type, whereas in the anti-HBe-positive phase a drastically reduced amount of HBV with many mutations remains, probably as a consequence of the long-lasting interaction with the host. Nevertheless, such small amount of virus could cause fulminant hepatic failure. It is important to make further clinical and virological investigations in order to understand the state of asymptomatic carrier.

摘要

在乙型肝炎病毒(HBV)感染过程中,存在一段肝功能检查正常但HBeAg/Ab状态不同的较长时期。由于无症状携带者中HBV的状态尚未得到充分表征,我们对HBeAg阳性和抗-HBe阳性无症状携带者的HBV进行了定量和定性检测。分析了10例HBeAg阳性和27例抗-HBe阳性无症状携带者的血清。通过斑点杂交和聚合酶链反应测定HBV DNA的量。通过对扩增的HBV DNA进行直接测序,检测乙型肝炎病毒前核心区和核心区跨度为636个核苷酸的突变。10例HBeAg阳性病例均检测到HBV DNA,而采用巢式PCR方法在27例抗-HBe阳性病例中仅7例(26%)检测到HBV DNA。HBeAg阳性病例中HBV DNA的平均量为10(9.1±0.7)拷贝/ml,而抗-HBe阳性病例中为10(1.0±1.5)拷贝/ml。从HBeAg阳性无症状携带者中获取的HBV DNA的整个前核心基因和核心基因均未发现错义突变。相比之下,在7例抗-HBe阳性无症状携带者的核心基因中检测到许多突变(平均9.0±3.3,范围6 - 14),其中2例突变增加。前核心区分析显示有3例野生型和4例突变型(包括1例与野生型共存)病例。这些数据表明,HBV在“无症状”携带者中以截然不同的方式存在;在HBeAg阳性阶段,HBV可能与宿主共存并保持野生型,而在抗-HBe阳性阶段,HBV数量大幅减少且存在许多突变,这可能是与宿主长期相互作用的结果。然而,如此少量的病毒仍可能导致暴发性肝衰竭。为了解无症状携带者的状态,进一步进行临床和病毒学研究很重要。

相似文献

1
The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.无症状携带者中乙肝病毒DNA的两种不同状态:HBe抗原阳性与抗-HBe阳性无症状携带者。
Dig Dis Sci. 1998 Feb;43(2):368-76. doi: 10.1023/a:1018870709286.
2
Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.抗-HBe阳性无症状携带者中的乙型肝炎病毒DNA
Intervirology. 2003;46(1):43-9. doi: 10.1159/000068123.
3
Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.日本乙肝病毒携带者中乙肝病毒核心区域氨基酸变化频率与前核心突变存在情况之间的关联
J Gastroenterol. 1997 Oct;32(5):611-22. doi: 10.1007/BF02934110.
4
Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg/anti-HBe status.无症状乙肝表面抗原携带者的乙肝病毒DNA:与e抗原/抗e抗体状态的比较
J Med Virol. 1987 Nov;23(3):233-9. doi: 10.1002/jmv.1890230305.
5
Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.乙肝e抗原阴性携带者中宿主-寄生虫动态关系的证据。
J Med Virol. 2002 Dec;68(4):505-12. doi: 10.1002/jmv.10241.
6
Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.通过聚合酶链反应检测到的低水平乙肝病毒血症伴随着乙肝病毒携带者中HBe抗原血症和肝炎的缺失。
Am J Gastroenterol. 1997 Jan;92(1):119-23.
7
Precore and core mutations in HBV from individuals in India with chronic infection.
J Med Virol. 1995 Mar;45(3):321-5. doi: 10.1002/jmv.1890450315.
8
Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.HBeAg阳性与抗-HBe阳性乙肝病毒携带者肝脏和血清中肝病、核心乙肝表面抗原、病毒复制及乙肝病毒DNA的分析
Hepatology. 1983 Sep-Oct;3(5):656-62. doi: 10.1002/hep.1840030505.
9
Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers.乙肝病毒携带者中乙肝病毒前C区缺陷突变株的流行情况。
J Med Virol. 1995 Aug;46(4):397-402. doi: 10.1002/jmv.1890460417.
10
[Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].[乙肝携带者中HBV-DNA定量与HBeAg、抗-HBe相关性的研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Aug;27(8):709-11.

引用本文的文献

1
Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.全球动力学和计算建模分析和控制乙型肝炎:一种新的流行方法。
PLoS One. 2024 Jun 27;19(6):e0304375. doi: 10.1371/journal.pone.0304375. eCollection 2024.
2
A study on fractional HBV model through singular and non-singular derivatives.一项关于通过奇异和非奇异导数的分数阶乙肝病毒模型的研究。
Eur Phys J Spec Top. 2022;231(10):1885-1904. doi: 10.1140/epjs/s11734-022-00460-6. Epub 2022 Mar 2.
3
Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B.

本文引用的文献

1
Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.被CD8 + 细胞毒性T淋巴细胞识别的天然加工的乙型肝炎病毒肽的纯化与鉴定
J Clin Invest. 1996 Jan 15;97(2):577-84. doi: 10.1172/JCI118450.
2
Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients.
J Med Virol. 1993 Apr;39(4):297-302. doi: 10.1002/jmv.1890390408.
3
Precore mutations and core clustering mutations in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中的前核心区突变和核心区聚集性突变
e抗原阴性慢性乙型肝炎患者中自然发生的核心免疫逃逸及羧基末端突变/截短
Hepatol Int. 2012 Oct;6(4):707-17. doi: 10.1007/s12072-011-9316-5. Epub 2011 Dec 2.
4
Current and future directions for treating hepatitis B virus infection.治疗乙型肝炎病毒感染的现状与未来方向。
World J Hepatol. 2015 Jun 18;7(11):1541-52. doi: 10.4254/wjh.v7.i11.1541.
5
New perspective on the natural course of chronic HBV infection.慢性乙型肝炎病毒感染自然病程的新视角
Front Med. 2014 Jun;8(2):129-34. doi: 10.1007/s11684-014-0339-x. Epub 2014 May 29.
6
Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.拉米夫定或恩替卡韦治疗慢性乙型肝炎急性加重的疗效。
Int J Med Sci. 2012;9(1):27-32. doi: 10.7150/ijms.9.27. Epub 2011 Nov 10.
7
Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India.印度北部 HBV 相关慢性肝病患者基因型及前核心/基本核心启动子突变的临床意义。
Dig Dis Sci. 2010 Mar;55(3):794-802. doi: 10.1007/s10620-009-1083-y. Epub 2009 Dec 31.
8
Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma.慢性感染儿童和肝细胞癌患者中不同的乙型肝炎病毒核心基因突变
Gut. 2003 Jan;52(1):122-5. doi: 10.1136/gut.52.1.122.
Gastroenterology. 1993 Jan;104(1):263-71. doi: 10.1016/0016-5085(93)90861-6.
4
The natural history of asymptomatic hepatitis B surface antigen carriers.无症状乙肝表面抗原携带者的自然病史。
Ann Intern Med. 1993 Feb 1;118(3):191-4. doi: 10.7326/0003-4819-118-3-199302010-00006.
5
Serology of acute exacerbation in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染急性加重期的血清学
Gastroenterology. 1993 Oct;105(4):1141-51. doi: 10.1016/0016-5085(93)90960-k.
6
Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers.慢性健康HBsAg/抗-HBe阳性携带者中“野生型”和“e-减型”乙型肝炎病毒感染的持续存在
J Hepatol. 1994 Jan;20(1):148-51. doi: 10.1016/s0168-8278(05)80482-9.
7
A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.蒙特利尔无症状乙肝表面抗原阳性携带者的长期随访研究
Gastroenterology. 1994 Apr;106(4):1000-5. doi: 10.1016/0016-5085(94)90760-9.
8
Characterization of hepatitis B virus core mutants that inhibit viral replication.抑制病毒复制的乙型肝炎病毒核心突变体的特征分析。
Virology. 1994 Nov 15;205(1):112-20. doi: 10.1006/viro.1994.1625.
9
The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study.乙肝病毒前核心区突变体在慢性乙肝病毒肝炎长期预后中的作用。一项纵向研究。
J Hepatol. 1994 Jun;20(6):773-81. doi: 10.1016/s0168-8278(05)80149-7.
10
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.乙型肝炎病毒核衣壳蛋白内最小最佳细胞毒性T细胞表位的定义。
J Virol. 1993 Apr;67(4):2376-80. doi: 10.1128/JVI.67.4.2376-2380.1993.